These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
7. 2-Thioxo-3,4-dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFR El-Gaby MSA; Abdel Reheim MAM; Akrim ZSM; Naguib BH; Saleh NM; El-Adasy ABAAM; El-Adl K; Mohamady S Drug Dev Res; 2024 Feb; 85(1):e22143. PubMed ID: 38349267 [TBL] [Abstract][Full Text] [Related]
8. New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies. Elkady H; Mahdy HA; Taghour MS; Dahab MA; Elwan A; Hagras M; Hussein MH; Ibrahim IM; Husein DZ; Elkaeed EB; Alsfouk AA; Metwaly AM; Eissa IH Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130599. PubMed ID: 38521471 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors. Farouk AKBAW; Abdelrasheed Allam H; Rashwan E; George RF; Abbas SE Bioorg Chem; 2022 Nov; 128():106099. PubMed ID: 35994884 [TBL] [Abstract][Full Text] [Related]